Modus Advisors, LLC Moderna, Inc. Transaction History

Modus Advisors, LLC

$305 Million
Q4 2024

A detailed history of Modus Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Modus Advisors, LLC holds 84 shares of MRNA stock, worth $3,549. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$3,549

% of portfolio

0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 03, 2025	BUY	$36.85 - $63.93 $3,095 - $5,370	84 New	84 $3,000
Q2 2023 Jul 05, 2023	SELL	$118.5 - $160.53 $42,778 - $57,951	-361 Reduced 16.03%	1,891 $229,000
Q1 2023 Apr 04, 2023	SELL	$135.66 - $197.02 $949 - $1,379	-7 Reduced 0.31%	2,252 $345,000
Q3 2022 Oct 05, 2022	BUY	$118.07 - $194.18 $15,231 - $25,049	129 Added 6.06%	2,259 $267,000
Q2 2022 Jul 05, 2022	BUY	$117.13 - $176.59 $249,486 - $376,136	2,130 New	2,130 $304,000
Q3 2021 Oct 08, 2021	SELL	$221.9 - $484.47 $443 - $968	-2 Closed	0 $0
Q2 2021 Jul 01, 2021	BUY	$129.91 - $234.98 $259 - $469	2 New	2 $0

Others Institutions Holding MRNA

# of Institutions

949

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modus Advisors, LLC with notifications on news.

Account